Neuphoria Therapeutics In...

5.04
-0.15 (-2.89%)
At close: Apr 25, 2025, 3:59 PM
5.04
0.00%
After-hours: Apr 25, 2025, 04:00 PM EDT

Neuphoria Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021 Jun 30, 2020 Jun 30, 2019 Jun 30, 2018 Jun 30, 2017
n/a n/a 181.36K n/a 32.06K 2.68M 2.76M 4.13M
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a 181.36K n/a 32.06K 2.68M 2.76M 4.13M
-17.89M -21.56M -14.68M -8.96M -6.19M -10.76M -21.28M -10.8M
220.1K 323.16K 6.79K 4.32K 40.11K 197.95K 422.32K 925.02K
-15.58M -21.52M -15.1M -6.68M -4.14M -6.94M -19.28M -4.79M
-15.49M -21.38M -14.97M -6.53M -4.89M -6.77M -18.43M -5.19M
8.47M 8.91M 5.27M 4.24M 3.33M 6.55M 4.97M 5.72M
9.42M 13.07M 11.01M 4.33M 4M 6.29M 18.55M 18.61M
n/a -422.74K -1.41M 386.74K -1.11M 596.83K 523.58K -9.4M
17.89M 21.56M 14.86M 8.96M 6.23M 13.43M 24.04M 14.93M
n/a 14.08K 18.48K 882.32K 1.23M 1.66M 1.51M 1.51M
n/a n/a n/a n/a n/a n/a n/a n/a
17.89M 21.56M 14.86M 8.96M 6.23M 13.43M 24.04M 14.93M
-87.32K -139.17K -131.95K -140.82K -142.65K -165.8K -852.96K 401.57K
149.8M 122.39M 112.78M 65M 45.41M 43.44M 40.19M 40.11M
149.8M 122.39M 112.78M 65M 45.41M 43.44M 40.19M 40.11M
-0.12 -0.36 -0.17 -0.13 -0.16 -0.22 -0.6 -0.17
-0.12 -0.36 -0.17 -0.13 -0.16 -0.22 -0.6 -0.17
-17.13M -20.9M -14.32M -4.51M -1.23M -5.28M -17.77M -3.27M
-17.8M -21.56M -15.08M -5.79M -2.91M -5.28M -17.77M -3.27M
662.99K 663.19K 763.17K 1.28M 1.68M 1.71M 1.67M 1.74M